BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001;121:710-723. [PMID: 11522755 DOI: 10.1053/gast.2001.27126] [Cited by in Crossref: 346] [Cited by in F6Publishing: 326] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Hai S, Kubo S, Shuto T, Tanaka H, Takemura S, Yamamoto T, Kanazawa A, Ogawa M, Hirohashi K, Wakasa K. Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases. Surg Today. 2006;36:390-394. [PMID: 16554999 DOI: 10.1007/s00595-005-3167-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
2 Parise ER, Oliveira AC. [Insulin resistance in chronic hepatitits C]. Arq Gastroenterol. 2007;44:178-184. [PMID: 17962866 DOI: 10.1590/S0004-28032007000200017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Albano E, Mottaran E, Occhino G, Reale E, Vidali M. Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Aliment Pharmacol Ther. 2005;22 Suppl 2:71-73. [PMID: 16225478 DOI: 10.1111/j.1365-2036.2005.02601.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 5.9] [Reference Citation Analysis]
4 Choung S, Kim JM, Joung KH, Lee ES, Kim HJ, Ku BJ. Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. PLoS One 2019;14:e0210828. [PMID: 30735525 DOI: 10.1371/journal.pone.0210828] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Pol S, Lebray P, Vallet-Pichard A. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. Clin Infect Dis 2004;38 Suppl 2:S65-72. [PMID: 14986277 DOI: 10.1086/381499] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
6 Gheflati A, Adelnia E, Nadjarzadeh A. The clinical effects of purslane ( Portulaca oleracea ) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. Phytotherapy Research 2019;33:1501-9. [DOI: 10.1002/ptr.6342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
7 Chaim FDM, Pascoal LB, Chaim FHM, Palma BB, Damázio TA, da Costa LBE, Carvalho R, Cazzo E, Gestic MA, Utrini MP, Milanski M, Chaim EA, Leal RF. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. Sci Rep 2020;10:8496. [PMID: 32444690 DOI: 10.1038/s41598-020-65556-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Hung DY, Siebert GA, Chang P, Burczynski FJ, Roberts MS. Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein. Am J Physiol Gastrointest Liver Physiol. 2005;288:G93-G100. [PMID: 15345470 DOI: 10.1152/ajpgi.00196.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
9 George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol. 2003;39:756-764. [PMID: 14568258 DOI: 10.1016/s0168-8278(03)00376-3] [Cited by in Crossref: 169] [Cited by in F6Publishing: 64] [Article Influence: 9.4] [Reference Citation Analysis]
10 Bastati N, Feier D, Wibmer A, Traussnigg S, Balassy C, Tamandl D, Einspieler H, Wrba F, Trauner M, Herold C, Ba-Ssalamah A. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. Radiology. 2014;271:739-747. [PMID: 24576046 DOI: 10.1148/radiol.14131890] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
11 Heller MT, Tublin ME. The role of ultrasonography in the evaluation of diffuse liver disease. Radiol Clin North Am. 2014;52:1163-1175. [PMID: 25444098 DOI: 10.1016/j.rcl.2014.07.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
12 Alves A, Mamede A, Alves M, Oliveira P, Rocha S, Botelho M, Maia C. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment? CCDT 2018;19:26-40. [DOI: 10.2174/1568009618666180430144441] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
13 Sull JW, Yun JE, Lee S, Ohrr H, Jee SH, Guallar E, Samet JM. Body Mass Index and Serum Aminotransferase Levels in Korean Men and Women. Journal of Clinical Gastroenterology 2009;43:869-75. [DOI: 10.1097/mcg.0b013e3181945956] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
14 Kopec KL, Burns D. Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. Nutr Clin Pract. 2011;26:565-576. [PMID: 21947639 DOI: 10.1177/0884533611419668] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
15 Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, Cheng GH, Liu P, Sun MY. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(15): 2771-2784 [PMID: 28487615 DOI: 10.3748/wjg.v23.i15.2771] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
16 Koek G, Liedorp P, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clinica Chimica Acta 2011;412:1297-305. [DOI: 10.1016/j.cca.2011.04.013] [Cited by in Crossref: 202] [Cited by in F6Publishing: 195] [Article Influence: 18.4] [Reference Citation Analysis]
17 Almahmoud MH, Al Khawaja NM, Alkinani A, Khader Y, Ajlouni KM. Prevalence of fatty liver disease and its associated factors among Jordanian patients with type 2 diabetes mellitus: A cross-sectional study. Ann Med Surg (Lond) 2021;68:102677. [PMID: 34401141 DOI: 10.1016/j.amsu.2021.102677] [Reference Citation Analysis]
18 Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl Res. 2007;149:114-125. [PMID: 17320797 DOI: 10.1016/j.trsl.2006.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
19 Orlando R, Azzalini L, Orando S, Lirussi F; Cochrane Hepato-Biliary Group. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd005160.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
20 Freitas ACTD, Freitas DTD, Parolin MB, Campos ACL, Coelho JCU. Doença hepática não-alcoólica: evolução após derivação gastrojejunal em Y-de-Roux pela técnica de fobi-capella. Arq Gastroenterol 2007;44:49-53. [DOI: 10.1590/s0004-28032007000100011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology. 2005;42:665-674. [PMID: 16116632 DOI: 10.1002/hep.20838] [Cited by in Crossref: 147] [Cited by in F6Publishing: 133] [Article Influence: 8.6] [Reference Citation Analysis]
22 Cederbaum AI. CYP2E1 – Biochemical and Toxicological Aspects and Role in Alcohol-Induced Liver Injury. In: Elfarra A, editor. Advances in Bioactivation Research. New York: Springer; 2008. pp. 1-36. [DOI: 10.1007/978-0-387-77300-1_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Yakaryilmaz F, Guliter S, Ozenirler S, Erdem O, Akyol G. Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients. Curr Ther Res Clin Exp 2004;65:266-77. [PMID: 24672082 DOI: 10.1016/S0011-393X(04)80077-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Shiga T, Shimbo T, Yoshizawa A. Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age. Birth Defects Res A Clin Mol Teratol 2015;103:787-93. [PMID: 26033770 DOI: 10.1002/bdra.23363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
25 Gadour E, Hassan Z, Gadour R. A Comprehensive Review of Transaminitis and Irritable Bowel Syndrome. Cureus 2021;13:e16583. [PMID: 34322359 DOI: 10.7759/cureus.16583] [Reference Citation Analysis]
26 Brunt EM, Tiniakos DG. Pathology of steatohepatitis. Best Practice & Research Clinical Gastroenterology 2002;16:691-707. [DOI: 10.1053/bega.2002.0326] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
27 Santamaria E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, Corrales FJ. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci USA. 2003;100:3065-3070. [PMID: 12631701 DOI: 10.1073/pnas.0536625100] [Cited by in Crossref: 118] [Cited by in F6Publishing: 117] [Article Influence: 6.2] [Reference Citation Analysis]
28 Assawarachan SN, Chuchalermporn P, Maneesaay P, Thengchaisri N. Changes in Serum Lipid Profiles among Canine Patients Suffering from Chronic Hepatitis. Vet Sci 2021;8:221. [PMID: 34679051 DOI: 10.3390/vetsci8100221] [Reference Citation Analysis]
29 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. Pathologe. 2010;31:225-237. [PMID: 20221762 DOI: 10.1007/s00292-010-1298-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
30 Li Y, Hai J, Li L, Chen X, Peng H, Cao M, Zhang Q. Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 2013;43:376-86. [DOI: 10.1007/s12020-012-9761-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
31 Hano H, Takasaki S, Kobayashi H, Koyama T, Lu T, Nagatsuma K. In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained. Virchows Arch 2013;462:533-40. [PMID: 23536281 DOI: 10.1007/s00428-013-1402-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
32 Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, Murakami T, Yorifuji T, Asayama K, Katayama S, Uemoto S, Kobayashi K, Takayanagi M, Fujisawa T, Tsukahara H. Relationship Between Oxidative Stress and Antioxidant Systems in the Liver of Patients With Wilson Disease: Hepatic Manifestation in Wilson Disease as a Consequence of Augmented Oxidative Stress. Pediatr Res 2006;60:472-7. [DOI: 10.1203/01.pdr.0000238341.12229.d3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
33 Fraenkel E, Takács R, Hamvas J, Lengyel G, Fehér J. [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]. Orv Hetil. 2007;148:793-798. [PMID: 17452309 DOI: 10.1556/hmj.1.2007.3.8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Sahai A, Malladi P, Melin-aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. American Journal of Physiology-Gastrointestinal and Liver Physiology 2004;287:G264-73. [DOI: 10.1152/ajpgi.00002.2004] [Cited by in Crossref: 137] [Cited by in F6Publishing: 133] [Article Influence: 7.6] [Reference Citation Analysis]
35 Okamura K, Okuda T, Takamiya Y, Shirai K, Urata H. High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes. Heart Vessels 2019;34:1559-69. [PMID: 30919112 DOI: 10.1007/s00380-019-01391-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Liu B, Zhang J, Sun P, Yi R, Han X, Zhao X. Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice. Biomolecules. 2019;9. [PMID: 31480575 DOI: 10.3390/biom9090435] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
37 Chiappini F, Barrier A, Saffroy R, Domart MC, Dagues N, Azoulay D, Sebagh M, Franc B, Chevalier S, Debuire B. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest. 2006;86:154-165. [PMID: 16344856 DOI: 10.1038/labinvest.3700374] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
38 Wijesundera KK, Izawa T, Tennakoon AH, Golbar HM, Tanaka M, Kuwamura M, Yamate J. M1-/M2-macrophage polarization in pseudolobules consisting of adipohilin-rich hepatocytes in thioacetamide (TAA)-induced rat hepatic cirrhosis. Exp Mol Pathol. 2016;101:133-142. [PMID: 27453055 DOI: 10.1016/j.yexmp.2016.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008;1:5. [PMID: 19014652 DOI: 10.1186/1755-1536-1-5] [Cited by in Crossref: 246] [Cited by in F6Publishing: 210] [Article Influence: 17.6] [Reference Citation Analysis]
40 Kakehashi A, Stefanov VE, Ishii N, Okuno T, Fujii H, Kawai K, Kawada N, Wanibuchi H. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. Int J Mol Sci 2017;18:E434. [PMID: 28218651 DOI: 10.3390/ijms18020434] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
41 Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H, Ohba K, Isomoto H, Mizuta Y, Hayashida K. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol. 2002;17:1098-1105. [PMID: 12201871 DOI: 10.1046/j.1440-1746.2002.02846.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 181] [Article Influence: 9.0] [Reference Citation Analysis]
42 Lonardo A, Loria P, Leonardi F, Ganazzi D, Carulli N. Growth hormone plasma levels in nonalcoholic fatty liver disease. Am J Gastroenterol. 2002;97:1071-1072. [PMID: 12003400 DOI: 10.1111/j.1572-0241.2002.05641.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
43 Afridi HI, Kazi TG, Kazi NG, Jamali MK, Sarfaraz RA, Arain MB, Kandhro GA, Shah AQ, Baig JA, Jalbani N. Determination of copper and iron in biological samples of viral hepatitis (A-E) female patients. Biol Trace Elem Res. 2009;129:78-87. [PMID: 19104758 DOI: 10.1007/s12011-008-8297-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
44 Rodríguez-Suárez E, Duce AM, Caballería J, Martínez Arrieta F, Fernández E, Gómara C, Alkorta N, Ariz U, Martínez-Chantar ML, Lu SC. Non-alcoholic fatty liver disease proteomics. Proteomics Clin Appl. 2010;4:362-371. [PMID: 21137056 DOI: 10.1002/prca.200900119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
45 Ruhl CE, Everhart JE. Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology 2003;124:1821-9. [DOI: 10.1016/s0016-5085(03)00395-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
46 Fotiadu A, Gagalis A, Akriviadis E, Kotoula V, Sinakos E, Karkavelas G, Hytiroglou P. Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease. Pathol Int 2010;60:87-92. [PMID: 20398192 DOI: 10.1111/j.1440-1827.2009.02489.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
47 Saxena NK, Saliba G, Floyd JJ, Anania FA. Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem 2003;89:311-20. [PMID: 12704794 DOI: 10.1002/jcb.10494] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 3.3] [Reference Citation Analysis]
48 Hsieh PS, Chan JY, Shyu JF, Chen YT, Loh CH. Mild portal endotoxaemia induces subacute hepatic inflammation and pancreatic beta-cell dysfunction in rats. Eur J Clin Invest. 2008;38:640-648. [PMID: 18837740 DOI: 10.1111/j.1365-2362.2008.01991.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
49 Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol. 2007;22:2009-2014. [PMID: 17914984 DOI: 10.1111/j.1440-1746.2006.04681.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
50 Tian YF, He CT, Chen YT, Hsieh PS. Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats. World J Gastroenterol 2013; 19(18): 2761-2771 [PMID: 23687413 DOI: 10.3748/wjg.v19.i18.2761] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
51 Matsumoto H, Tamura S, Kamada Y, Kiso S, Fukushima J, Wada A, Maeda N, Kihara S, Funahashi T, Matsuzawa Y, Shimomura I, Hayashi N. Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J Gastroenterol 2006; 12(21): 3352-3358 [PMID: 16733851 DOI: 10.3748/wjg.v12.i21.3352] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
52 Lefkowitch JH. Liver histopathology. Clin Liver Dis 2002;6:xv-xix. [PMID: 12122872 DOI: 10.1016/s1089-3261(02)00015-6] [Reference Citation Analysis]
53 Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673 [PMID: 26819531 DOI: 10.3748/wjg.v22.i4.1664] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
54 Krier M, Ahmed A. The asymptomatic outpatient with abnormal liver function tests. Clin Liver Dis. 2009;13:167-177. [PMID: 19442912 DOI: 10.1016/j.cld.2009.02.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
55 Milroy CM. Fatty Liver and the Forensic Pathologist. Acad Forensic Pathol 2018;8:296-310. [PMID: 31240043 DOI: 10.1177/1925362118782061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Ann Surg Oncol 2007;14:1170-81. [PMID: 17195904 DOI: 10.1245/s10434-006-9299-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
57 Watanabe S, Kumazaki S, Kusunoki K, Inoue T, Maeda Y, Usui S, Shinohata R, Ohtsuki T, Hirohata S, Kusachi S, Kitamori K, Mori M, Yamori Y, Oka H. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats. J Atheroscler Thromb 2018;25:439-53. [PMID: 29162773 DOI: 10.5551/jat.40956] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
58 Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004;126:586-597. [PMID: 14762795 DOI: 10.1053/j.gastro.2003.11.020] [Cited by in Crossref: 318] [Cited by in F6Publishing: 297] [Article Influence: 17.7] [Reference Citation Analysis]
59 Silva GH, Hessel G, Coelho KIR, Escanhoela CAF. Steatosis of indeterminate cause in a pediatric group: is it a primary mitochondrial hepatopathy? Sao Paulo Med J 2011;129:217-23. [DOI: 10.1590/s1516-31802011000400004] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
60 Herath HMM, Kodikara I, Weerarathna TP, Liyanage G. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:246-50. [DOI: 10.1016/j.dsx.2018.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
61 Colles SL, Dixon JB, Marks P, Strauss BJ, O’brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. The American Journal of Clinical Nutrition 2006;84:304-11. [DOI: 10.1093/ajcn/84.2.304] [Cited by in Crossref: 228] [Cited by in F6Publishing: 114] [Article Influence: 14.3] [Reference Citation Analysis]
62 Nomoto K, Tsuneyama K, Takahashi H, Murai Y, Takano Y. Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease. Appl Immunohistochem Mol Morphol. 2008;16:71-75. [PMID: 18091316 DOI: 10.1097/pai.0b013e31803156d5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
63 Inafuku M, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama H, Toda T, Yanagita T. Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. Br J Nutr 2012;107:639-46. [PMID: 21787451 DOI: 10.1017/S0007114511003485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
64 Takeshita Y, Takamura T, Hamaguchi E, Shimizu A, Ota T, Sakurai M, Kaneko S. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line. Metabolism 2006;55:1464-72. [PMID: 17046548 DOI: 10.1016/j.metabol.2006.06.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
65 Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, Simard S, Marceau P. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135:48-58. [PMID: 14694300 DOI: 10.1016/j.surg.2003.10.003] [Cited by in Crossref: 222] [Cited by in F6Publishing: 193] [Article Influence: 12.3] [Reference Citation Analysis]
66 Wang Y, Li J, Zhuge L, Su D, Yang M, Tao S, Li J. Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. Exp Ther Med 2014;7:663-8. [PMID: 24520264 DOI: 10.3892/etm.2013.1461] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
67 Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2007; 13(26): 3540-3553 [PMID: 17659704 DOI: 10.3748/wjg.v13.i26.3540] [Cited by in CrossRef: 160] [Cited by in F6Publishing: 148] [Article Influence: 10.7] [Reference Citation Analysis]
68 Scartabelli G, Querci G, Marconi L, Ceccarini G, Piaggi P, Fierabracci P, Salvetti G, Cizza G, Mazzeo S, Vitti J, Berger S, Palla A, Santini F. Liver Enlargement Predicts Obstructive Sleep Apnea-Hypopnea Syndrome in Morbidly Obese Women. Front Endocrinol (Lausanne) 2018;9:293. [PMID: 29928260 DOI: 10.3389/fendo.2018.00293] [Reference Citation Analysis]
69 Tao GZ, Toivola DM, Zhong B, Michie SA, Resurreccion EZ, Tamai Y, Taketo MM, Omary MB. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury. J Cell Sci 2003;116:4629-38. [PMID: 14576356 DOI: 10.1242/jcs.00782] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
70 Conde de la Rosa L, Schoemaker MH, Vrenken TE, Buist-Homan M, Havinga R, Jansen PL, Moshage H. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J Hepatol. 2006;44:918-929. [PMID: 16310883 DOI: 10.1016/j.jhep.2005.07.034] [Cited by in Crossref: 146] [Cited by in F6Publishing: 144] [Article Influence: 8.6] [Reference Citation Analysis]
71 Goldstein NS, Hastah F, Galan MV, Gordon SC. Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens. Am J Clin Pathol. 2005;123:382-387. [PMID: 15716234 DOI: 10.1309/ey72f1en9xcb1kxx] [Cited by in Crossref: 66] [Cited by in F6Publishing: 1] [Article Influence: 3.9] [Reference Citation Analysis]
72 Nadeau K, Klingensmith G, Sokol RJ. Nonalcoholic steatohepatitis in a teenage girl with type 2 diabetes: . Current Opinion in Pediatrics 2003;15:127-31. [DOI: 10.1097/00008480-200302000-00021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
73 Igolnikov AC, Green RM. Mice heterozygous for the Mdr2 gene demonstrate decreased PEMT activity and diminished steatohepatitis on the MCD diet. J Hepatol 2006;44:586-92. [PMID: 16376450 DOI: 10.1016/j.jhep.2005.08.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
74 Kawasaki S, Hasegawa O, Satoh S, Numata K, Terauchi Y. Sonographic assessment of fatty liver infiltration using the measurement of para- and perirenal fat thickness. J Clin Ultrasound 2010;38:470-4. [DOI: 10.1002/jcu.20736] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
75 Bencheqroun R, Duvoux C, Luciani A, Zafrani ES, Dhumeaux D. [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis]. Gastroenterol Clin Biol. 2004;28:497-499. [PMID: 15243330 DOI: 10.1016/s0399-8320(04)94971-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
76 Gangadhar K, Chintapalli KN, Cortez G, Nair SV. MRI evaluation of fatty liver in day to day practice: Quantitative and qualitative methods. The Egyptian Journal of Radiology and Nuclear Medicine 2014;45:619-26. [DOI: 10.1016/j.ejrnm.2014.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
77 Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol. 2002;17:1136-1143. [PMID: 12453271 DOI: 10.1046/j.1440-1746.2002.02881.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 119] [Article Influence: 7.1] [Reference Citation Analysis]
78 Rutherford A, Davern T, Hay JE, Murray NG, Hassanein T, Lee WM, Chung RT. Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol. 2006;4:1544-1549. [PMID: 16996806 DOI: 10.1016/j.cgh.2006.07.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
79 Kahraman A, Miller M, Gieseler RK, Gerken G, Scolaro MJ, Canbay A. Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases. Eur J Gastroenterol Hepatol 2006;18:101-5. [PMID: 16357628 DOI: 10.1097/00042737-200601000-00018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
80 Marra F. Leptin and liver fibrosis: a matter of fat. Gastroenterology 2002;122:1529-32. [PMID: 11984539 DOI: 10.1053/gast.2002.33369] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
81 Gwack J, Hwang S, Ko K, Jun JK, Park SK, Chang S, Shin H, Yoo K. Fasting Serum Glucose and Subsequent Liver Cancer Risk in a Korean Prospective Cohort. J Prev Med Public Health 2007;40:23. [DOI: 10.3961/jpmph.2007.40.1.23] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
82 Miyaoka H, Michitaka K, Tokumoto Y, Miyake T, Shigematsu S, Soga Y, Abe M, Hiasa Y, Matsuura B, Horiike N, Onji M. LAPAROSCOPIC FEATURES AND INTEROBSERVER VARIATION OF HISTOLOGICAL DIAGNOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: LAPAROSCOPY AND HISTOLOGY OF NAFLD. Digestive Endoscopy 2008;20:22-8. [DOI: 10.1111/j.1443-1661.2007.00771.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:S74-S83. [PMID: 12407579 DOI: 10.1053/jhep.2002.36807] [Cited by in Crossref: 34] [Cited by in F6Publishing: 135] [Article Influence: 1.7] [Reference Citation Analysis]
84 Kurita S, Takamura T, Ota T, Matsuzawa-nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. European Journal of Pharmacology 2008;588:316-24. [DOI: 10.1016/j.ejphar.2008.04.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
85 Lapenna D, Ciofani G, Festi D, Neri M, Pierdomenico SD, Giamberardino MA, Cuccurullo F. Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol. 2002;64:1661-1667. [PMID: 12429355 DOI: 10.1016/s0006-2952(02)01391-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
86 Koh WP, Wang R, Jin A, Yu MC, Yuan JM. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer. 2013;108:1182-1188. [PMID: 23370206 DOI: 10.1038/bjc.2013.25] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
87 Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, Fernandez-Merino C, Vidal C. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151:42-50. [PMID: 18005364 DOI: 10.1111/j.1365-2249.2007.03545.x] [Cited by in Crossref: 313] [Cited by in F6Publishing: 288] [Article Influence: 20.9] [Reference Citation Analysis]
88 Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1-16. [PMID: 16436109 DOI: 10.1111/j.0959-9673.2006.00465.x] [Cited by in Crossref: 487] [Cited by in F6Publishing: 482] [Article Influence: 30.4] [Reference Citation Analysis]
89 Manoria P, Inamdar S, Kumar R. Hepatobiliary dysfunction in Type-2 diabetes mellitus. J Family Med Prim Care 2017;6:563-7. [PMID: 29417009 DOI: 10.4103/2249-4863.222018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
90 Lee PC, Yang LY, Wang YW, Huang SF, Lee KC, Hsieh YC, Yang YY, Hsieh SL, Hou MC, Lin HC, Lee FY, Lee SD. Mechanisms of the prevention and inhibition of the progression and development of non-alcoholic steatohepatitis by genetic and pharmacological decoy receptor 3 supplementation. Hepatol Res 2017;47:1260-71. [PMID: 28066964 DOI: 10.1111/hepr.12863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
91 Nomoto K, Nishida T, Nakanishi Y, Fujimoto M, Takasaki I, Tabuchi Y, Tsuneyama K. Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease. ScientificWorldJournal. 2012;2012:959824. [PMID: 22593713 DOI: 10.1100/2012/959824] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
92 Tanné F, Gagnadoux F, Chazouillères O, Fleury B, Wendum D, Lasnier E, Lebeau B, Poupon R, Serfaty L. Chronic liver injury during obstructive sleep apnea. Hepatology. 2005;41:1290-1296. [PMID: 15915459 DOI: 10.1002/hep.20725] [Cited by in Crossref: 162] [Cited by in F6Publishing: 148] [Article Influence: 9.5] [Reference Citation Analysis]
93 Kitade M, Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Sawai M, Yoshida M, Morioka C, Tsujimoto T, Kawaratani H, Fukui H. Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis. World J Gastroenterol 2009; 15(41): 5193-5199 [PMID: 19891019 DOI: 10.3748/wjg.15.5193] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
94 Tokar JL, Berg CL. Therapeutic options in nonalcoholic fatty liver disease. Curr Treat Options Gastro 2002;5:425-36. [DOI: 10.1007/s11938-002-0030-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
95 Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH. Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med. 2004;15:10-21. [PMID: 15066643 DOI: 10.1016/j.ejim.2003.12.008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
96 Elahi MM, Cagampang FR, Mukhtar D, Anthony FW, Ohri SK, Hanson MA. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. Br J Nutr. 2009;102:514-519. [PMID: 19203419 DOI: 10.1017/s000711450820749x] [Cited by in Crossref: 166] [Cited by in F6Publishing: 78] [Article Influence: 12.8] [Reference Citation Analysis]
97 Hayashi PH, Harrison SA, Torgerson S, Perez TA, Nochajski T, Russell M. Cognitive Lifetime Drinking History in Nonalcoholic Fatty Liver Disease: Some Cases May Be Alcohol Related. Am J Gastroenterol 2004;99:76-81. [DOI: 10.1046/j.1572-0241.2003.04013.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
98 Bell DS, Allbright E. The multifaceted associations of hepatobiliary disease and diabetes. Endocr Pract 2007;13:300-12. [PMID: 17599864 DOI: 10.4158/EP.13.3.300] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
99 Schroyen B, Guimarães EL, Dollé L, Coulon S, Empsen C, Nyssen M, Geerts A, Colle I, Geerts A, van Grunsven LA. Leptin-mediated reactive oxygen species production does not significantly affect primary mouse hepatocyte functions in vitro: . European Journal of Gastroenterology & Hepatology 2012;24:1370-80. [DOI: 10.1097/meg.0b013e328357ce1c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
100 Lee D, Lim J, Yang J, Ha M, Jacobs DR. Serum gamma-glutamyltransferase within its normal range predicts a chronic elevation of alanine aminotransferase: A four year follow-up study. Free Radical Research 2009;39:589-93. [DOI: 10.1080/10715760400016154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
101 Iorio R, Sepe A, Giannattasio A, Cirillo F, Spagnuolo MI, Franzese A, Fontana S, Aufiero D, Perna F, Vegnente A, Matarese G. Immune Phenotype and Serum Leptin in Children with Obesity-Related Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2006;91:341-4. [DOI: 10.1210/jc.2005-1054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
102 Denk H, Stumptner C, Fuchsbichler A, Zatloukal K. Mallory bodies and liver diseases. J Gastroenterol Hepatol 2004;19:S349-52. [DOI: 10.1111/j.1440-1746.2004.03649.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Ozaki A, Yoneda M, Kessoku T, Iwaki M, Kobayashi T, Honda Y, Ogawa Y, Imajo K, Sakai E, Taguri M, Yamanaka T, Iwasaki T, Kurihashi T, Saito S, Nakajima A. Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study). Contemp Clin Trials Commun 2020;17:100516. [PMID: 31956725 DOI: 10.1016/j.conctc.2019.100516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
104 Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, Paradis V, Corre MP, Prat L, Kuoch V, Basdevant A. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int. 2005;25:946-953. [PMID: 16162151 DOI: 10.1111/j.1478-3231.2005.01126.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
105 Kitade M, Yoshiji H, Kojima H, Ikenaka Y, Noguchi R, Kaji K, Yoshii J, Yanase K, Namisaki T, Asada K. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepatology. 2006;44:983-991. [PMID: 17006938 DOI: 10.1002/hep.21338] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 5.9] [Reference Citation Analysis]
106 Fardet A, Chardigny J. Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition 2013;53:535-90. [DOI: 10.1080/10408398.2010.549596] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
107 Seki S, Sakaguchi H, Kitada T, Iwai S, Fujii H, Enomoto M, Habu D, Tamori A. Laparoscopic findings in non-alcoholic steatohepatitis. Dig Endosc 2003;15:306-10. [DOI: 10.1046/j.1443-1661.2003.t01-1-00263.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol. 2011;55:1391-1399. [PMID: 21703208 DOI: 10.1016/j.jhep.2011.02.035] [Cited by in Crossref: 149] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
109 Mohamed Salih S, Nallasamy P, Muniyandi P, Periyasami V, Carani Venkatraman A. Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. J Diabetes. 2009;1:278-287. [PMID: 20923528 DOI: 10.1111/j.1753-0407.2009.00045.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
110 Yu HB, Dai L, Peng HY, Mou XC, Zuo Z. Effects of compound from Chinese medicine on oxidation and anti-oxidation system of rat liver with steatohepatitis induced by high-fat diets. Shijie Huaren Xiaohua Zazhi 2005; 13(24): 2842-2847 [DOI: 10.11569/wcjd.v13.i24.2842] [Reference Citation Analysis]
111 Candelli M, Nista EC, Pignataro G, Zannoni G, de Pascalis B, Gasbarrini G, Gasbarrini A. Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation. J Intern Med 2003;253:391-2. [DOI: 10.1046/j.1365-2796.2003.01108.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
112 Alchera E, Imarisio C, Mandili G, Merlin S, Chandrashekar BR, Novelli F, Follenzi A, Carini R. Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype. Biomed Res Int 2015;2015:286746. [PMID: 26539478 DOI: 10.1155/2015/286746] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
113 Tomic D, Kemp WW, Roberts SK. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol 2018;30:1103-15. [PMID: 30113367 DOI: 10.1097/MEG.0000000000001235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
114 Kurinami N, Sugiyama S, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, Jinnouch K, Jinnouchi T, Jinnouchi H. Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2018;142:254-63. [DOI: 10.1016/j.diabres.2018.05.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
115 Yeh MM, Brunt EM. Pathology of fatty liver: differential diagnosis of non-alcoholic fatty liver disease. Diagnostic Histopathology 2008;14:586-97. [DOI: 10.1016/j.mpdhp.2008.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
116 Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009;21:673-680. [PMID: 19318971 DOI: 10.1097/meg.0b013e32831bc3d6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
117 Fukunishi S, Nishio H, Fukuda A, Takeshita A, Hanafusa T, Higuchi K, Suzuki K. Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa/fa) Rats. J Clin Biochem Nutr. 2009;45:322-328. [PMID: 19902023 DOI: 10.3164/jcbn.09-50] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
118 Zhan YT, Zhang C, Li L, Bi CS, Song X, Zhang ST. Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in Type 2 Diabetes. Int J Mol Sci 2012;13:14698-706. [PMID: 23203089 DOI: 10.3390/ijms131114698] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
119 Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clinical Nutrition 2007;26:409-15. [DOI: 10.1016/j.clnu.2007.02.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
120 Tiao MM, Lin TK, Kuo FY, Huang CC, Du YY, Chen CL, Chuang JH. Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. J Pediatr Gastroenterol Nutr 2007;45:329-34. [PMID: 17873745 DOI: 10.1097/MPG.0b013e3180cc2c0f] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
121 Papatheodoridis GV, Goulis J, Christodoulou D, Manolakopoulos S, Raptopoulou M, Andrioti E, Alexandropoulos N, Savvidou S, Papachristou A, Zervou E. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity. Eur J Gastroenterol Hepatol. 2007;19:281-287. [PMID: 17353691 DOI: 10.1097/meg.0b013e328011438b] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
122 Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002;123:1367-84. [DOI: 10.1053/gast.2002.36061] [Cited by in Crossref: 308] [Cited by in F6Publishing: 259] [Article Influence: 15.4] [Reference Citation Analysis]
123 Baba CS, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Choudhuri G. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 2006;21:191-8. [DOI: 10.1111/j.1440-1746.2005.04233.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 123] [Article Influence: 8.3] [Reference Citation Analysis]
124 Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71-79. [PMID: 12512031 DOI: 10.1053/gast.2003.50004] [Cited by in Crossref: 405] [Cited by in F6Publishing: 364] [Article Influence: 21.3] [Reference Citation Analysis]
125 Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28:637-653. [PMID: 25194181 DOI: 10.1016/j.bpg.2014.07.008] [Cited by in Crossref: 189] [Cited by in F6Publishing: 167] [Article Influence: 23.6] [Reference Citation Analysis]
126 Kolachi NF, Kazi TG, Afridi HI, Kazi N, Kandhro GA, Shah AQ, Baig JA, Wadhwa SK, Khan S, Shah F, Jamali MK, Arain MB. Distribution of copper, iron, and zinc in biological samples (scalp hair, serum, blood, and urine) of Pakistani viral hepatitis (A-E) patients and controls. Biol Trace Elem Res 2011;143:116-30. [PMID: 20872092 DOI: 10.1007/s12011-010-8852-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
127 Mirza MS. Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol. 2011;2011:592404. [PMID: 21991518 DOI: 10.5402/2011/592404] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 5.7] [Reference Citation Analysis]
128 Miller M, Kahraman A, Ross B, Beste M, Gerken G. Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy. Eur J Med Res 2009;14:369-77. [PMID: 19748856 DOI: 10.1186/2047-783x-14-9-369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 Kinoshita N, Horie Y, Ohshima S, Hirai Y, Dohmen T, Jin M, Matsuhashi T, Sasaki J, Sasaki T, Iizuka M, Ohnishi H. Epimorphin protects hepatocytes from oxidative stress by inhibiting mitochondrial injury. J Gastroenterol Hepatol 2011;26:201-6. [PMID: 21175815 DOI: 10.1111/j.1440-1746.2010.06327.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
130 Neri S, Pulvirenti D, Signorelli S, Ignaccolo L, Tsami A, Mauceri B, Misseri M, Interlandi D, Cutuli N, Castellino P. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations. Intern Med J 2008;38:254-8. [PMID: 17916170 DOI: 10.1111/j.1445-5994.2007.01474.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
131 Zhan YT, An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(37): 4652-4660 [PMID: 20872965 DOI: 10.3748/wjg.v16.i37.4652] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
132 Arain SA, Afridi HI, Kazi TG, Talpur FN, Shah F, Arain SS, Panhwar AH, Brahman KD. Investigation of Alteration in the Levels of Iron and Copper in Scalp Hair Samples of Patients Having Different Types of Viral Hepatitis. Biol Trace Elem Res 2013;156:5-11. [DOI: 10.1007/s12011-013-9832-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
133 Lugari S, Mantovani A, Nascimbeni F, Lonardo A. Hypothyroidism and nonalcoholic fatty liver disease - a chance association? Horm Mol Biol Clin Investig 2018;41:/j/hmbci. [PMID: 30367792 DOI: 10.1515/hmbci-2018-0047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
134 Pallayova M, Taheri S. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies. Clin Obes. 2014;4:243-253. [PMID: 25825857 DOI: 10.1111/cob.12068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
135 Okanoue T, Sakamoto M, Harada K, Inagaki M, Totsuka N, Hashimoto G, Kumada H. Efficacy and safety of apararenone (MT-3995) in patients with nonalcoholic steatohepatitis: A randomized controlled study. Hepatol Res 2021;51:943-56. [PMID: 34260795 DOI: 10.1111/hepr.13695] [Reference Citation Analysis]
136 Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology. 2008;48:109-118. [PMID: 18571789 DOI: 10.1002/hep.22338] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
137 Alberici LC, Oliveira HC, Catharino RR, Vercesi AE, Eberlin MN, Alberici RM. Distinct hepatic lipid profile of hypertriglyceridemic mice determined by easy ambient sonic-spray ionization mass spectrometry. Anal Bioanal Chem 2011;401:1651-9. [PMID: 21732042 DOI: 10.1007/s00216-011-5208-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
138 Kiki I, Altunkaynak BZ, Altunkaynak ME, Vuraler O, Unal D, Kaplan S. Effect of high fat diet on the volume of liver and quantitative feature of Kupffer cells in the female rat: a stereological and ultrastructural study. Obes Surg. 2007;17:1381-1388. [PMID: 18000736 DOI: 10.1007/s11695-007-9219-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
139 Pasricha S, Kenney-Hunt J, Anderson K, Jafari N, Hall RA, Lammert F, Cheverud J, Green RM. Identification of eQTLs for hepatic Xbp1s and Socs3 gene expression in mice fed a high-fat, high-caloric diet. G3 (Bethesda) 2015;5:487-96. [PMID: 25617409 DOI: 10.1534/g3.115.016626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
140 Zamir D, Linova L, Amir T, Lebedev V, Polychuck I, Leibovitz I, Reitblat T, Weiler Z, Peled R, Lebovici O. Prediction of Fatty Liver: Comparison of Body Mass Index, Visceral Fat, and Subcutaneous Fat: . Journal of Clinical Gastroenterology 2003;36:281-2. [DOI: 10.1097/00004836-200303000-00019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
141 Kosmidou IS, Aggarwal A, Ross JJ, Worthington MG. Hodgkin’ s disease with fulminant non-alcoholic steatohepatitis. Dig Liver Dis. 2004;36:691-693. [PMID: 15506670 DOI: 10.1016/j.dld.2003.12.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
142 Trunečka P, Míková I, Dlouhá D, Hubáček JA, Honsová E, Kolesár L, Lánská V, Fraňková S, Šperl J, Jirsa M, Poledne R. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. Dig Liver Dis 2018;50:490-5. [PMID: 29396131 DOI: 10.1016/j.dld.2017.12.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
143 Magalotti D, Marchesini G, Ramilli S, Berzigotti A, Bianchi G, Zoli M. Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment. A pilot study. Dig Liver Dis 2004;36:406-11. [PMID: 15248381 DOI: 10.1016/j.dld.2004.01.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
144 Alberici LC, Oliveira HC, Patrício PR, Kowaltowski AJ, Vercesi AE. Hyperlipidemic Mice Present Enhanced Catabolism and Higher Mitochondrial ATP-Sensitive K+ Channel Activity. Gastroenterology 2006;131:1228-34. [DOI: 10.1053/j.gastro.2006.07.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
145 Mathur SK, Jain P, Mathur P. Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications. J Obes 2011;2011:587495. [PMID: 21603273 DOI: 10.1155/2011/587495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
146 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011;458:511-523. [PMID: 21442288 DOI: 10.1007/s00428-011-1066-1].] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Takeuchi K, Yokouchi C, Goto H, Umehara K, Yamada H, Ishii Y. Alleviation of fatty liver in a rat model by enhancing N1-methylnicotinamide bioavailability through aldehyde oxidase inhibition. Biochemical and Biophysical Research Communications 2018;507:203-10. [DOI: 10.1016/j.bbrc.2018.11.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
148 Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis. 2004;8:535-47, viii. [PMID: 15331062 DOI: 10.1016/j.cld.2004.04.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
149 He L, Liu X, Wang L, Yang Z. Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials. Medicine (Baltimore) 2016;95:e4947. [PMID: 27759627 DOI: 10.1097/MD.0000000000004947] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
150 Rodríguez-Hernández H, Gonzalez JL, Rodríguez-Morán M, Guerrero-Romero F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch Med Res 2005;36:362-6. [PMID: 15950075 DOI: 10.1016/j.arcmed.2005.03.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
151 Xu C, Wang YL, Zhang HQ, Liu ZZ, Hao Y, Niu JZ, Li JX. Effects of Gegen Qinglian Tang on high-fat diet-induced non-alcoholic steatohepatitis in rats. Shijie Huaren Xiaohua Zazhi 2014; 22(4): 546-552 [DOI: 10.11569/wcjd.v22.i4.546] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
152 Zaitone SA, Barakat BM, Bilasy SE, Fawzy MS, Abdelaziz EZ, Farag NE. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:587-600. [PMID: 25708949 DOI: 10.1007/s00210-015-1102-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
153 Reuben A. Leave gourmandising. Hepatology 2002;36:1303-6. [PMID: 12395350 DOI: 10.1002/hep.510360543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
154 Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, Aihara Y, Namisaki T, Yoshii J, Yanase K. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1094-G1104. [PMID: 21372165 DOI: 10.1152/ajpgi.00365.2010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
155 Arya A, Azarmehr N, Mansourian M, Doustimotlagh AH. Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies. Arch Physiol Biochem 2019;:1-8. [PMID: 31475569 DOI: 10.1080/13813455.2019.1659827] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
156 Tannapfel A, Denk H, Dienes H, Langner C, Schirmacher P, Trauner M, Flott-rahmel B. Histopathologische Diagnose der nichtalkoholischen und alkoholischen Fettlebererkrankung: Konsensusbasierte Leitlinie der Stufe 2. Pathologe 2010;31:225-37. [DOI: 10.1007/s00292-010-1274-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
157 Fernando H, Kondraganti S, Bhopale KK, Volk DE, Neerathilingam M, Kaphalia BS, Luxon BA, Boor PJ, Shakeel Ansari GA. ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver. Alcohol Clin Exp Res 2010;34:1937-47. [PMID: 20682011 DOI: 10.1111/j.1530-0277.2010.01283.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
158 Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, Van Meter A, Younoszai A, Goodman Z, Baranova A. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int. 2005;25:760-771. [PMID: 15998427 DOI: 10.1111/j.1478-3231.2005.01117.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 4.5] [Reference Citation Analysis]
159 Graham DJ, Drinkard CR, Shatin D. Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone. Am J Gastroenterology 2003;98:175-9. [DOI: 10.1111/j.1572-0241.2003.07175.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
160 Takamura T, Sakurai M, Ota T, Ando H, Honda M, Kaneko S. Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. Diabetologia 2004;47:638-47. [PMID: 15298340 DOI: 10.1007/s00125-004-1366-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
161 Zarkovic K, Jakovcevic A, Zarkovic N. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases. Free Radic Biol Med 2017;111:110-26. [PMID: 27993730 DOI: 10.1016/j.freeradbiomed.2016.12.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
162 Jorgensen RA. Nonalcoholic Fatty liver disease. Gastroenterol Nurs 2003;26:150-4; quiz 154-5. [PMID: 12920429 DOI: 10.1097/00001610-200307000-00003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
163 Romagnoli M, Gomez-Cabrera MC, Perrelli MG, Biasi F, Pallardó FV, Sastre J, Poli G, Viña J. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radic Biol Med 2010;49:171-7. [PMID: 20362663 DOI: 10.1016/j.freeradbiomed.2010.03.024] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
164 Dou AX, Zong L, Zhou K, Chen T, Pan H, Zhang Q, Li JQ, Fang JY, Lu LG. Experimental study on nonalcoholic fatty liver disease treated by medical instrument on hepatic diseases of type Ⅰ DSG in rats. Shijie Huaren Xiaohua Zazhi 2008; 16(9): 935-940 [DOI: 10.11569/wcjd.v16.i9.935] [Reference Citation Analysis]
165 Tous M, Ferré N, Rull A, Marsillach J, Coll B, Alonso-villaverde C, Camps J, Joven J. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochemical and Biophysical Research Communications 2006;340:1078-84. [DOI: 10.1016/j.bbrc.2005.12.109] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
166 Song F, Xie ML, Zhu LJ, Zhang KP, Xue J, Gu ZL. Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals. World J Gastroenterol 2006; 12(27): 4359-4363 [PMID: 16865778 DOI: 10.3748/wjg.v12.i27.4359] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
167 Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Tsuchiya K, Nagatani Y, Mukaisho K, Takahashi M, Murata K. The Possibility of differentiation between nonalcoholic steatohepatitis and fatty liver in rabbits on Gd-EOB-DTPA-enhanced open-type MRI scans. Acad Radiol. 2011;18:525-529. [PMID: 21237679 DOI: 10.1016/j.acra.2010.11.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
168 Zhang HF, Shi LJ, Song GY, Cai ZG, Wang C, An RJ. Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation. Food Chem Toxicol 2013;55:70-7. [PMID: 23295629 DOI: 10.1016/j.fct.2012.12.043] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
169 Pan M, Song YL, Xu JM, Gan HZ. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. J Pineal Res. 2006;41:79-84. [PMID: 16842545 DOI: 10.1111/j.1600-079x.2006.00346.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
170 Cortez-pinto H, Ermelinda Camilo M. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Practice & Research Clinical Gastroenterology 2004;18:1089-104. [DOI: 10.1016/j.bpg.2004.06.021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
171 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011;458:511-523. [PMID: 21442288 DOI: 10.1007/s00428-011-1066-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
172 Yakaryilmaz F, Guliter S, Savas B, Erdem O, Ersoy R, Erden E, Akyol G, Bozkaya H, Ozenirler S. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-? expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. Intern Med J 2007;37:229-35. [DOI: 10.1111/j.1445-5994.2006.01295.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
173 Samadi N, Cembrowski GS, Chan J. Effect of waist circumference on reference intervals of liver-related enzyme tests in apparently healthy adult Mexican Americans, black and white Americans. Clinical Biochemistry 2007;40:206-12. [DOI: 10.1016/j.clinbiochem.2006.11.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
174 Yan E, Durazo F, Tong M, Hong K. Nonalcoholic Fatty Liver Disease: Pathogenesis, Identification, Progression, and Management. Nutrition Reviews 2007;65:376-84. [DOI: 10.1111/j.1753-4887.2007.tb00315.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
175 Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr. 2005;59:723-726. [PMID: 15770222 DOI: 10.1038/sj.ejcn.1602127] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 7.0] [Reference Citation Analysis]
176 Gyamfi MA, Damjanov I, French S, Wan YJ. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem Pharmacol. 2008;75:981-995. [PMID: 18036573 DOI: 10.1016/j.bcp.2007.09.030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
177 Anticoli S, Arciello M, Mancinetti A, De Martinis M, Ginaldi L, Iuliano L, Balsano C. 7-ketocholesterol and 5,6-secosterol modulate differently the stress-activated mitogen-activated protein kinases (MAPKs) in liver cells. J Cell Physiol 2010;222:586-95. [PMID: 19937729 DOI: 10.1002/jcp.21972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
178 Mikami K, Endo T, Sawada N, Igarashi G, Kimura M, Hasegawa T, Iino C, Tomita H, Sawada K, Nakaji S, Matsuzaka M, Torok NJ, Fukuda S. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population. Cytokine 2020;126:154927. [PMID: 31756645 DOI: 10.1016/j.cyto.2019.154927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
179 Cao Q, Mak KM, Lieber CS. Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J Cell Biochem. 2006;97:188-197. [PMID: 16173077 DOI: 10.1002/jcb.20622] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
180 Kim JH, Suk S, Jang WJ, Lee CH, Kim J, Park J, Kweon M, Kim JH, Lee KW. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet: Effect of Salicornia -extracted salt…. Journal of Food Science 2017;82:1765-74. [DOI: 10.1111/1750-3841.13777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
181 Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol. 2006;44:S28-S34. [PMID: 16343684 DOI: 10.1016/j.jhep.2005.11.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
182 Rotondo C, Corrado A, Mansueto N, Cici D, Corsi F, Pennella A, Paolo Cantatore F. Pfeifer-Weber-Christian Disease: A Case Report and Review of Literature on Visceral Involvements and Treatment Choices. Clin Med Insights Case Rep 2020;13:1179547620917958. [PMID: 32528225 DOI: 10.1177/1179547620917958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palù G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;292:G518-25. [DOI: 10.1152/ajpgi.00024.2006] [Cited by in Crossref: 534] [Cited by in F6Publishing: 531] [Article Influence: 35.6] [Reference Citation Analysis]
184 Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, Sasaki S, Nishiguchi S, Maeyama S. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722-730. [PMID: 17559420 DOI: 10.1111/j.1872-034x.2007.00130.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
185 Chiu C, Lee W, Wang W, Lee Y, Huang M. Correlations of Laparoscopy with Histology and Laboratory Studies on Liver Diseases in Bariatric Patients. OBES SURG 2008;18:204-11. [DOI: 10.1007/s11695-007-9354-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
186 Amali AA, Rekha RD, Lin CJ, Wang WL, Gong HY, Her GM, Wu JL. Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis. J Biomed Sci. 2006;13:225-232. [PMID: 16456712 DOI: 10.1007/s11373-005-9055-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
187 Zheng RD, Chen JN, Zhuang QY, Lu YH, Chen J, Chen BF. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis. Int J Med Sci. 2013;10:641-646. [PMID: 23569427 DOI: 10.7150/ijms.5649] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
188 Ratziu V, Tahiri M, Bonyhay L. La stéatohépatite non alcoolique. Annales d'Endocrinologie 2005;66:71-80. [DOI: 10.1016/s0003-4266(05)81735-4] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
189 Bora A, Alptekin C, Yavuz A, Batur A, Akdemir Z, Berköz M. Assessment of liver volume with computed tomography and comparison of findings with ultrasonography. Abdom Imaging 2014;39:1153-61. [PMID: 24777593 DOI: 10.1007/s00261-014-0146-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
190 Perrini S, Tortosa F, Natalicchio A, Pacelli C, Cignarelli A, Palmieri VO, Caccioppoli C, De Stefano F, Porro S, Leonardini A, Ficarella R, De Fazio M, Cocco T, Puglisi F, Laviola L, Palasciano G, Giorgino F. The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells. Am J Physiol Gastrointest Liver Physiol 2015;309:G826-40. [PMID: 26336926 DOI: 10.1152/ajpgi.00041.2015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
191 Evans CD, Oien KA, MacSween RN, Mills PR. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol 2002;55:689-92. [PMID: 12195000 DOI: 10.1136/jcp.55.9.689] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 3.5] [Reference Citation Analysis]
192 Molyvdas A, Georgopoulou U, Lazaridis N, Hytiroglou P, Dimitriadis A, Foka P, Vassiliadis T, Loli G, Phillipidis A, Zebekakis P, Germenis AE, Speletas M, Germanidis G. The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation. Cytokine 2018;110:389-96. [PMID: 29803661 DOI: 10.1016/j.cyto.2018.04.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
193 Pietu F, Guillaud O, Walter T, Vallin M, Hervieu V, Scoazec JY, Dumortier J. Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. Clin Res Hepatol Gastroenterol 2012;36:146-55. [PMID: 22154224 DOI: 10.1016/j.clinre.2011.10.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
194 El-Serag HB, Everhart JE. Diabetes increases the risk of acute hepatic failure. Gastroenterology 2002;122:1822-8. [PMID: 12055590 DOI: 10.1053/gast.2002.33650] [Cited by in Crossref: 108] [Cited by in F6Publishing: 85] [Article Influence: 5.4] [Reference Citation Analysis]
195 Takeuchi-Yorimoto A, Noto T, Yamada A, Miyamae Y, Oishi Y, Matsumoto M. Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation. Toxicol Appl Pharmacol 2013;268:264-77. [PMID: 23481610 DOI: 10.1016/j.taap.2013.01.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
196 Su DM, Zhuge L, Li J, Yang MJ, Liu YX, Li JX. A mouse model of non-alcoholic steatohepatitis induced by feeding a methionine-choline-deficient diet: establishment and dynamic monitoring. Shijie Huaren Xiaohua Zazhi 2011; 19(11): 1122-1129 [DOI: 10.11569/wcjd.v19.i11.1122] [Reference Citation Analysis]
197 Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology. 2006;130:2023-2030. [PMID: 16762625 DOI: 10.1053/j.gastro.2006.03.019] [Cited by in Crossref: 170] [Cited by in F6Publishing: 160] [Article Influence: 10.6] [Reference Citation Analysis]
198 Ehx G, Gérin S, Mathy G, Franck F, Oliveira HC, Vercesi AE, Sluse FE. Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels. Lipids Health Dis 2014;13:116. [PMID: 25047818 DOI: 10.1186/1476-511X-13-116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
199 Gyamfi MA, Tanaka Y, He L, Klaassen CD, Wan YJ. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. Toxicol Appl Pharmacol 2009;234:166-78. [PMID: 18952117 DOI: 10.1016/j.taap.2008.09.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
200 Sikaris KA. The Clinical Biochemistry of Obesity—More Than Skin Deep. Heart, Lung and Circulation 2007;16:S45-50. [DOI: 10.1016/j.hlc.2007.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
201 Kohli R, Boyd T, Lake K, Dietrich K, Nicholas L, Balistreri WF, Ebach D, Shashidhar H, Xanthakos SA. Rapid progression of NASH in childhood. J Pediatr Gastroenterol Nutr 2010;50:453-6. [PMID: 20179647 DOI: 10.1097/MPG.0b013e3181a9387b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
202 Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC; Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008;47:1363-70. [PMID: 18366115 DOI: 10.1002/hep.22109] [Cited by in Crossref: 431] [Cited by in F6Publishing: 390] [Article Influence: 30.8] [Reference Citation Analysis]
203 Lee SH, Kim KN, Kim KM, Joo NS. Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome. Yonsei Med J 2016;57:146-52. [PMID: 26632395 DOI: 10.3349/ymj.2016.57.1.146] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
204 Liangpunsakul S, Chalasani N. Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis?: . Journal of Clinical Gastroenterology 2003;37:340-3. [DOI: 10.1097/00004836-200310000-00014] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
205 Armutcu F, Akyol S, Ucar F, Erdogan S, Akyol O. Markers in Nonalcoholic Steatohepatitis. Elsevier; 2013. pp. 67-125. [DOI: 10.1016/b978-0-12-407680-8.00004-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Meroni M, Longo M, Dongiovanni P. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients. 2019;11. [PMID: 31689910 DOI: 10.3390/nu11112642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
207 Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, Degos F, Farges O, Belghiti J. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl. 2004;10:S69-S73. [PMID: 14762843 DOI: 10.1002/lt.20033] [Cited by in Crossref: 151] [Cited by in F6Publishing: 133] [Article Influence: 8.4] [Reference Citation Analysis]
208 Dourakis SP, Sevastianos VA, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol. 2002;97:1074-1075. [PMID: 12003403 DOI: 10.1111/j.1572-0241.2002.05644.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
209 Sánchez-muñoz D, Castellano-megías VM, Romero-gómez M. Case Report: Histologic Features of Steatohepatitis in Patients with a Clinical Diagnosis of Autoimmune Cholestasis. Dig Dis Sci 2004;49:1957-61. [DOI: 10.1007/s10620-004-9600-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
210 Eckard C, Cole R, Lockwood J, Torres DM, Williams CD, Shaw JC, Harrison SA. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol. 2013;6:249-259. [PMID: 23814606 DOI: 10.1177/1756283x13484078] [Cited by in Crossref: 69] [Cited by in F6Publishing: 37] [Article Influence: 7.7] [Reference Citation Analysis]
211 Tanaka N, Kono H, Ishii K, Hosomura N, Fujii H. Dietary olive oil prevents carbon tetrachloride-induced hepatic fibrosis in mice. J Gastroenterol 2009;44:983-90. [DOI: 10.1007/s00535-009-0088-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
212 Rodriguez-Suarez E, Mato JM, Elortza F. Proteomics analysis of human nonalcoholic fatty liver. Methods Mol Biol. 2012;909:241-258. [PMID: 22903720 DOI: 10.1007/978-1-61779-959-4_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
213 Smellie WS. Testing pitfalls and summary of guidance in lipid management. BMJ 2006;333:83-6. [PMID: 16825231 DOI: 10.1136/bmj.333.7558.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
214 Hsieh PS. Inflammatory change of fatty liver induced by intraportal low-dose lipopolysaccharide infusion deteriorates pancreatic insulin secretion in fructose-induced insulin-resistant rats. Liver Int. 2008;28:1167-1175. [PMID: 18397237 DOI: 10.1111/j.1478-3231.2008.01714.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
215 Ucar F, Sezer S, Erdogan S, Akyol S, Armutcu F, Akyol O. The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. Redox Rep. 2013;18:127-133. [PMID: 23743495 DOI: 10.1179/1351000213y.0000000050] [Cited by in Crossref: 66] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
216 Masarone M, La Mura V, Bruno S, Gaeta GB, Vecchione R, Carrino F, Moschella F, Torella R, Persico M. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease. J Viral Hepat. 2007;14:714-720. [PMID: 17875006 DOI: 10.1111/j.1365-2893.2007.00861.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
217 Kim K, Lim Y, Kim K, Yoon J, Lee H. 15d-Deoxy-Δ12,14-prostaglandin J2 modulates collagen type I synthesis in human hepatic stellate cells by inducing oxidative stress. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:361-7. [DOI: 10.1016/j.plefa.2005.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
218 Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of Diffuse Liver Disease. Journal of Ultrasound in Medicine 2002;21:1023-32. [DOI: 10.7863/jum.2002.21.9.1023] [Cited by in Crossref: 164] [Cited by in F6Publishing: 129] [Article Influence: 8.2] [Reference Citation Analysis]
219 Poullis AP, Shetty AK, Risley PD, Collinson PO, Mendall MA. Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity. Eur J Gastroenterol Hepatol 2003;15:1317-22. [PMID: 14624155 DOI: 10.1097/00042737-200312000-00010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
220 Alchera E, Rolla S, Imarisio C, Bardina V, Valente G, Novelli F, Carini R. Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. Transl Res 2017;182:75-87. [PMID: 28011152 DOI: 10.1016/j.trsl.2016.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
221 O’Brien J, Powell LW. Non-alcoholic fatty liver disease: is iron relevant? Hepatol Int. 2012;6:332-341. [PMID: 22020821 DOI: 10.1007/s12072-011-9304-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
222 Fraenkel E, Takács R, Hamvas J, Lengyel G, Fehér J. Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis. Orvosi Hetilap 2007;148:793-8. [DOI: 10.1556/oh.2007.28049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
223 Amacher DE. Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies. Toxicology 2011;279:10-8. [PMID: 20974209 DOI: 10.1016/j.tox.2010.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
224 Conde de la Rosa L, Vrenken TE, Hannivoort RA, Buist-Homan M, Havinga R, Slebos DJ, Kauffman HF, Faber KN, Jansen PL, Moshage H. Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform. Free Radic Biol Med 2008;44:1323-33. [PMID: 18206660 DOI: 10.1016/j.freeradbiomed.2007.12.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
225 Chitturi S, Farrell GC, George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J Gastroenterol Hepatol. 2004;19:368-374. [PMID: 15012772 DOI: 10.1111/j.1440-1746.2003.03252.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 5.6] [Reference Citation Analysis]
226 Di Sario A, Candelaresi C, Omenetti A, Benedetti A. Vitamin E in chronic liver diseases and liver fibrosis. Vitam Horm 2007;76:551-73. [PMID: 17628189 DOI: 10.1016/S0083-6729(07)76021-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
227 Blonski W, Reddy KR. Hepatitis C Virus Infection and Hepatocellular Carcinoma. Clinics in Liver Disease 2008;12:661-74. [DOI: 10.1016/j.cld.2008.03.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
228 Walker RW, Sinatra F, Hartiala J, Weigensberg M, Spruijt-Metz D, Alderete TL, Goran MI, Allayee H. Genetic and clinical markers of elevated liver fat content in overweight and obese Hispanic children. Obesity (Silver Spring) 2013;21:E790-7. [PMID: 23804528 DOI: 10.1002/oby.20523] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
229 Albright ES, Bell DSH. The Liver, Liver Disease, and Diabetes Mellitus: . The Endocrinologist 2003;13:58-66. [DOI: 10.1097/00019616-200301000-00011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
230 Brunt EM, Tiniakos DG. Steatosis, steatohepatitis: Review of effects on chronic hepatitis C. Current Hepatitis Reports 2002;1:38-44. [DOI: 10.1007/s11901-002-0007-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
231 Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, Kawamura M, Ebihara K, Onji M. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition. 2007;23:46-52. [PMID: 17140767 DOI: 10.1016/j.nut.2006.09.004] [Cited by in Crossref: 165] [Cited by in F6Publishing: 150] [Article Influence: 10.3] [Reference Citation Analysis]
232 Caballería Rovira L, Torán Montserrat P, Auladell Llorens MA, Pera Blanco G. [Non-alcoholic hepatic steatosis. An update]. Aten Primaria 2008;40:419-24. [PMID: 18755103 DOI: 10.1157/13125408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
233 Caballería J, Rodés J. [Non-alcoholic steatohepatitis]. Med Clin (Barc) 2003;120:670-5. [PMID: 12747817 DOI: 10.1016/s0025-7753(03)73803-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
234 Woodford RM, Burton PR, O'Brien PE, Laurie C, Brown WA. Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes. Obes Surg. 2015;25:1858-1862. [PMID: 25708241 DOI: 10.1007/s11695-015-1623-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
235 Yamato I, Takayama T, Midorikawa Y, Higaki T, Nakayama H, Moriguchi M, Nakajima Y, Matsuoka S, Ogawa M, Moriyama M. Postoperative outcomes of patients with hepatocellular carcinoma negative for all virus-related markers. Surg Today 2013;43:865-70. [DOI: 10.1007/s00595-012-0308-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Xu CF, Yu CH, Li YM, Xu L, Du J, Shen Z. Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease. World J Gastroenterol 2007; 13(33): 4504-4508 [PMID: 17724809 DOI: 10.3748/wjg.v13.i33.4504] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
237 Zois CD, Baltayiannis GH, Bekiari A, Goussia A, Karayiannis P, Doukas M, Demopoulos D, Mitsellou A, Vougiouklakis T, Mitsi V, Tsianos EV. Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J Gastroenterol 2010; 16(31): 3944-3949 [PMID: 20712056 DOI: 10.3748/wjg.v16.i31.3944] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
238 Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y. Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis. Diabetes Metab Syndr Obes 2018;11:835-43. [PMID: 30568471 DOI: 10.2147/DMSO.S184767] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
239 Dahlke MH, Popp FC, Larsen S, Schlitt HJ, Rasko JE. Stem cell therapy of the liver? Fusion or fiction? Liver Transpl 2004;10:471-9. [DOI: 10.1002/lt.20121] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
240 Rubio A, Guruceaga E, Vázquez-Chantada M, Sandoval J, Martínez-Cruz LA, Segura V, Sevilla JL, Podhorski A, Corrales FJ, Torres L. Identification of a gene-pathway associated with non-alcoholic steatohepatitis. J Hepatol. 2007;46:708-718. [PMID: 17275126 DOI: 10.1016/j.jhep.2006.10.021] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
241 Allison ME. Fatty liver. Hosp Med 2004;65:609-12. [PMID: 15524341 DOI: 10.12968/hosp.2004.65.10.16611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
242 Altlparmak E, Köklü S, Yallnklllc M, Yüksel O, Cicek B, Kayacetin E, Sahin T. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol 2005; 11(20): 3056-3059 [PMID: 15918189 DOI: 10.3748/wjg.v11.i20.3056] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
243 Méndez-sánchez N, Motola-kuba D, Bahena-aponte J, Chavez-tapia N, Pichardo-bahena R, Uribe M. Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report. Annals of Hepatology 2003;2:183-5. [DOI: 10.1016/s1665-2681(19)32132-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
244 Choi KM. Non-alcoholic Fatty Liver Disease and Adiponectin. Korean Diabetes J 2008;32:98. [DOI: 10.4093/kdj.2008.32.2.98] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
245 Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology. 2006;49:450-465. [PMID: 17064291 DOI: 10.1111/j.1365-2559.2006.02416.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 168] [Article Influence: 11.3] [Reference Citation Analysis]
246 Huber DA. Nonalcoholic Steatohepatitis (NASH) Syndrome: . Gastroenterology Nursing 2004;27:55-8. [DOI: 10.1097/00001610-200403000-00004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
247 Fazel I, Pourshams A, Merat S, Hemayati R, Sotoudeh M, Malekzadeh R. Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up. J Gastrointest Surg 2007;11:1033-8. [PMID: 17514410 DOI: 10.1007/s11605-007-0184-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
248 Yoshiji H, Noguchi R, Ikenaka Y, Namisaki T, Kitade M, Kaji K, Shirai Y, Yoshii J, Yanase K, Yamazaki M. Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat. BMC Res Notes. 2009;2:70. [PMID: 19416517 DOI: 10.1186/1756-0500-2-70] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
249 Regev A, Palmer M, Avigan MI, Dimick-Santos L, Treem WR, Marcinak JF, Seekins D, Krishna G, Anania FA, Freston JW, Lewis JH, Sanyal AJ, Chalasani N. Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2019;49:702-13. [PMID: 30761572 DOI: 10.1111/apt.15153] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
250 Nomoto K, Tsuneyama K, Abdel Aziz HO, Takahashi H, Murai Y, Cui ZG, Fujimoto M, Kato I, Hiraga K, Hsu DK. Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice. J Pathol. 2006;210:469-477. [PMID: 17029217 DOI: 10.1002/path.2065] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
251 Watanabe S, Kumazaki S, Yamamoto S, Sato I, Kitamori K, Mori M, Yamori Y, Hirohata S. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model. Int J Exp Pathol 2018;99:282-94. [PMID: 30680827 DOI: 10.1111/iep.12301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
252 Harrison SA, Kadakia S, Lang KA, Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol. 2002;97:2714-2724. [PMID: 12425538 DOI: 10.1111/j.1572-0241.2002.07069.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 46] [Article Influence: 0.5] [Reference Citation Analysis]
253 Hermos JA, Cohen SA, Hall R, Gagnon DR, Brophy MT, Fiore LD. Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients. Diabetes Res Clin Pract 2008;80:153-8. [PMID: 18178283 DOI: 10.1016/j.diabres.2007.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
254 Zafrani ES. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 2004;444:3-12. [PMID: 14685853 DOI: 10.1007/s00428-003-0943-7] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
255 Hashimoto E, Tokushige K, Ludwig J. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges. Hepatol Res. 2015;45:20-28. [PMID: 24661406 DOI: 10.1111/hepr.12333] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
256 Bellentani S, Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver. Eur J Gastroenterol Hepatol. 2004;16:1087-1093. [PMID: 15489565 DOI: 10.1097/00042737-200411000-00002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
257 van de Wier B, Balk JM, Bast A, Koek GH, Haenen GR. Chemical characteristics for optimizing CYP2E1 inhibition. Chem Biol Interact 2015;242:139-44. [PMID: 26428356 DOI: 10.1016/j.cbi.2015.09.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
258 Conde de la Rosa L, Vrenken TE, Buist-Homan M, Faber KN, Moshage H. Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. Pharmacol Res Perspect. 2015;3:e00125. [PMID: 26038701 DOI: 10.1002/prp2.125] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
259 Jolly RA, Ciurlionis R, Morfitt D, Helgren M, Patterson R, Ulrich RG, Waring JF. Microvesicular Steatosis Induced by a Short Chain Fatty Acid: Effects on Mitochondrial Function and Correlation with Gene Expression. Toxicol Pathol 2004;32:19-25. [DOI: 10.1080/01926230490451699] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
260 Nanji AA. Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis. 2004;8:559-574, ix. [PMID: 15331064 DOI: 10.1016/j.cld.2004.04.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
261 Muangpaisarn P, Jampoka K, Payungporn S, Wisedopas N, Bunchorntavakul C, Tangkijvanich P, Treeprasertsuk S. Serum microRNA-34a is potential biomarker for inflammation in nonalcoholic fatty liver disease. Asian Biomedicine 2017;10:163-71. [DOI: 10.5372/1905-7415.1002.478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
262 Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1035-G1043. [PMID: 15256362 DOI: 10.1152/ajpgi.00199.2004] [Cited by in Crossref: 198] [Cited by in F6Publishing: 198] [Article Influence: 11.0] [Reference Citation Analysis]
263 Imarisio C, Alchera E, Sutti S, Valente G, Boccafoschi F, Albano E, Carini R. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats. Clin Sci (Lond). 2012;123:323-332. [PMID: 22439844 DOI: 10.1042/cs20110504] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
264 Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17(48): 5240-5245 [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
265 Solga SF, Diehl AM. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol. 2003;38:681-687. [PMID: 12713883 DOI: 10.1016/s0168-8278(03)00097-7] [Cited by in Crossref: 124] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
266 Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci. 2005;50:171-180. [PMID: 15712657 DOI: 10.1007/s10620-005-1267-z] [Cited by in Crossref: 166] [Cited by in F6Publishing: 162] [Article Influence: 9.8] [Reference Citation Analysis]
267 Kanda T, Yokosuka O, Suzuki Y. Prolonged hepatitis caused by cytomegalovirus and non-alcoholic steatohepatitis in 16-year-old obese boy. Eur J Pediatr 2005;164:212-5. [PMID: 15682313 DOI: 10.1007/s00431-004-1584-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
268 Kon K, Ikejima K, Morinaga M, Kusama H, Arai K, Aoyama T, Uchiyama A, Yamashina S, Watanabe S. L-carnitine prevents metabolic steatohepatitis in obese diabetic KK-A y mice: L-carnitine prevents murine steatohepatitis. Hepatol Res 2017;47:E44-54. [DOI: 10.1111/hepr.12720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
269 Stärkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, Horsmans Y. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol. 2003;39:538-546. [PMID: 12971963 DOI: 10.1016/s0168-8278(03)00360-x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
270 Merat S, Malekzadeh R, Sohrabi MR, Hormazdi M, Naserimoghadam S, Mikaeli J, Farahvash MJ, Ansari R, Sotoudehmanesh R, Khatibian M. Probucol in the Treatment of Nonalcoholic Steatohepatitis: An Open-Labeled Study. Journal of Clinical Gastroenterology 2003;36:266-8. [DOI: 10.1097/00004836-200303000-00015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
271 El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:S74-S83. [PMID: 12407579 DOI: 10.1002/hep.1840360710] [Cited by in Crossref: 195] [Cited by in F6Publishing: 127] [Article Influence: 9.8] [Reference Citation Analysis]
272 Rekha RD, Amali AA, Her GM, Yeh YH, Gong HY, Hu SY, Lin GH, Wu JL. Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology. 2008;243:11-22. [PMID: 17997003 DOI: 10.1016/j.tox.2007.09.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
273 Kikuchi M, Tomita K, Nakahara T, Kitamura N, Teratani T, Irie R, Yokoyama H, Suzuki T, Yokoyama T, Taguchi T. Utility of quantitative 99mTc-phytate scintigraphy to diagnose early-stage non-alcoholic steatohepatitis. Scand J Gastroenterol. 2009;44:229-236. [PMID: 18819037 DOI: 10.1080/00365520802433249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
274 Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009;51:371-9. [PMID: 19501928 DOI: 10.1016/j.jhep.2009.03.019] [Cited by in Crossref: 353] [Cited by in F6Publishing: 335] [Article Influence: 27.2] [Reference Citation Analysis]
275 Mishra A, Younossi ZM. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease. J Clin Exp Hepatol. 2012;2:135-144. [PMID: 25755422 DOI: 10.1016/s0973-6883(12)60102-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
276 Zhao P, Saltiel AR. From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases. J Biol Chem 2020;295:12279-89. [PMID: 32651233 DOI: 10.1074/jbc.REV120.011356] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 9.5] [Reference Citation Analysis]
277 Rosenstengel S, Stoeppeler S, Bahde R, Spiegel HU, Palmes D. Type of steatosis influences microcirculation and fibrogenesis in different rat strains. J Invest Surg. 2011;24:273-282. [PMID: 22047200 DOI: 10.3109/08941939.2011.586094] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
278 Hübscher SG. Alcohol-Induced Liver Disease. Practical Hepatic Pathology: A Diagnostic Approach. Elsevier; 2011. pp. 417-33. [DOI: 10.1016/b978-0-443-06803-4.00030-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
279 Singh DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic Steatohepatitis. Dig Dis Sci 2008;53:1967-76. [DOI: 10.1007/s10620-007-0074-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
280 Yoneda M, Mawatari H, Fujita K, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol. 2007;42:375-381. [PMID: 17530362 DOI: 10.1007/s00535-2014-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
281 Kalyesubula M, Mopuri R, Asiku J, Rosov A, Yosefi S, Edery N, Bocobza S, Moallem U, Dvir H. High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition. Dis Model Mech 2021;14:dmm048355. [PMID: 33608323 DOI: 10.1242/dmm.048355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
282 Wu X, Gong C, Weinstock J, Cheng J, Hu S, Venners SA, Hsu YH, Wu S, Zha X, Jiang S, Li Y, Pan F, Xu X. Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia. Clin Appl Thromb Hemost 2018;24:240S-7S. [PMID: 30336686 DOI: 10.1177/1076029618805863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
283 Dove LM. A general approach to the management of chronic hepatitis C. Gastroenterology Clinics of North America 2004;33:463-77. [DOI: 10.1016/j.gtc.2004.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
284 Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res. 2005;29:259S-263S. [PMID: 16385233 DOI: 10.1097/01.alc.0000191776.37626.30] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
285 Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ, Chen SY. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003; 9(5): 1106-1110 [PMID: 12717867 DOI: 10.3748/wjg.v9.i5.1106] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 108] [Article Influence: 6.2] [Reference Citation Analysis]
286 Spaniol M, Kaufmann P, Beier K, Wüthrich J, Török M, Scharnagl H, März W, Krähenbühl S. Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. Journal of Lipid Research 2003;44:144-53. [DOI: 10.1194/jlr.m200200-jlr200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
287 Chitturi S, George J. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep 2003;5:18-25. [DOI: 10.1007/s11894-003-0005-y] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
288 Merat S, Malekzadeh R, Sohrabi MR, Sotoudeh M, Rakhshani N, Sohrabpour AA, Naserimoghadam S. Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study. J Hepatol 2003;38:414-8. [PMID: 12663231 DOI: 10.1016/s0168-8278(02)00441-5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
289 Ajioka RS, Phillips JD, Weiss RB, Dunn DM, Smit MW, Proll SC, Katze MG, Kushner JP. Down-regulation of hepcidin in porphyria cutanea tarda. Blood 2008;112:4723-8. [PMID: 18809758 DOI: 10.1182/blood-2008-02-138222] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
290 Robert K, Nehmé J, Bourdon E, Pivert G, Friguet B, Delcayre C, Delabar JM, Janel N. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 2005;128:1405-15. [PMID: 15887121 DOI: 10.1053/j.gastro.2005.02.034] [Cited by in Crossref: 122] [Cited by in F6Publishing: 121] [Article Influence: 7.2] [Reference Citation Analysis]
291 Davila JA, Petersena NJ, Nelson HA, El-Serag HB. Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003;56:487-493. [PMID: 12812824 DOI: 10.1016/s0895-4356(02)00605-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
292 Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol. 2009;83:519-548. [PMID: 19448996 DOI: 10.1007/s00204-009-0432-0] [Cited by in Crossref: 368] [Cited by in F6Publishing: 354] [Article Influence: 28.3] [Reference Citation Analysis]
293 Pedrosa de Oliveira C, Sobroza de Mello E, Af Alves V, Mahmud Saviero S, Strauss E. Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity. Annals of Hepatology 2007;6:255-61. [DOI: 10.1016/s1665-2681(19)31907-6] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
294 Riley P, Sudarshi D, Johal M, Benedict A, Panteli J, Crook M, O’donohue J. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study: Weight loss, diet and statins in NAFLD. International Journal of Clinical Practice 2008;62:374-81. [DOI: 10.1111/j.1742-1241.2007.01666.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
295 Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett. 2007;581:5664-5670. [PMID: 18022391 DOI: 10.1016/j.febslet.2007.11.023] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 8.3] [Reference Citation Analysis]
296 Lall CG, Aisen AM, Bansal N, Sandrasegaran K. Nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2008;190:993-1002. [PMID: 18356447 DOI: 10.2214/ajr.07.2052] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
297 Loguercio C, Federico A, Trappoliere M, Tuccillo C, de Sio I, Di Leva A, Niosi M, D’Auria MV, Capasso R, Del Vecchio Blanco C. The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci. 2007;52:2387-2395. [PMID: 17410454 DOI: 10.1007/s10620-006-9703-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
298 Barr J, Vázquez-Chantada M, Alonso C, Pérez-Cormenzana M, Mayo R, Galán A, Caballería J, Martín-Duce A, Tran A, Wagner C. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res. 2010;9:4501-4512. [PMID: 20684516 DOI: 10.1021/pr1002593] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 10.1] [Reference Citation Analysis]
299 Sahai A, Pan X, Paul R, Malladi P, Kohli R, Whitington PF. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium. Am J Physiol Gastrointest Liver Physiol. 2006;291:G55-G62. [PMID: 16439472 DOI: 10.1152/ajpgi.00360.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
300 Ku NO, Darling JM, Krams SM, Esquivel CO, Keeffe EB, Sibley RK, Lee YM, Wright TL, Omary MB. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci U S A 2003;100:6063-8. [PMID: 12724528 DOI: 10.1073/pnas.0936165100] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 4.0] [Reference Citation Analysis]
301 Chavez-Tapia NC, Sanchez-Avila F, Vasquez-Fernandez F, Torres-Machorro A, Tellez-Avila FI, Uribe M. Non-alcoholic fatty-liver disease in pediatric populations. J Pediatr Endocrinol Metab 2007;20:1059-73. [PMID: 18051925 DOI: 10.1515/jpem.2007.20.10.1059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
302 Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2002;18:290-8. [PMID: 17033299 DOI: 10.1097/00001574-200205000-00002] [Reference Citation Analysis]
303 Wei P, Taniguchi S, Sakai Y, Imamura M, Inoguchi T, Nawata H, Oda S, Nakabeppu Y, Nishimura J, Ikuyama S. Expression of adipose differentiation-related protein (ADRP) is conjointly regulated by PU.1 and AP-1 in macrophages. J Biochem 2005;138:399-412. [PMID: 16272134 DOI: 10.1093/jb/mvi136] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
304 Guan YS, He Q. A current update on the rule of alternative and complementary medicine in the treatment of liver diseases. Evid Based Complement Alternat Med 2013;2013:321234. [PMID: 24109491 DOI: 10.1155/2013/321234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
305 Yoneda M, Mawatari H, Fujita K, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol. 2007;42:375-381. [PMID: 17530362 DOI: 10.1007/s00535-007-2014-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
306 Castéra L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani ES, Pawlotsky JM, Dhumeaux D. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003;52:288-92. [PMID: 12524415 DOI: 10.1136/gut.52.2.288] [Cited by in Crossref: 217] [Cited by in F6Publishing: 200] [Article Influence: 11.4] [Reference Citation Analysis]
307 Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol. 2003;3:27. [PMID: 14561231 DOI: 10.1186/1471-230x-3-27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
308 Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev. 2004;5:27-42. [PMID: 14969505 DOI: 10.1111/j.1467-789x.2004.00126.x] [Cited by in Crossref: 186] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
309 Riley P, O'Donohue J, Crook M. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J Clin Pathol 2007;60:1384-91. [PMID: 17483247 DOI: 10.1136/jcp.2006.044891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
310 Sarı A, Tunakan M, Ozmen M, Turkkan E. Ground-glass-like hepatocellular inclusions in the course of adult-onset Still’s disease. Modern Rheumatology 2014;20:90-2. [DOI: 10.3109/s10165-009-0233-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
311 Tomita K, Tanimoto A, Irie R, Kikuchi M, Yokoyama H, Teratani T, Suzuki T, Taguchi T, Noguchi M, Ohkura T. Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2008;28:1444-1450. [PMID: 19025953 DOI: 10.1002/jmri.21596] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
312 Jo M, Nishikawa T, Nakajima T, Okada Y, Yamaguchi K, Mitsuyoshi H, Yasui K, Minami M, Iwai M, Kagawa K. Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma. J Gastroenterol. 2011;46:809-821. [PMID: 21452000 DOI: 10.1007/s00535-011-0392-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
313 Hyun HJ, Shim J, Kim J, Lee JS, Lee CK, Jang JY, Kim B. The Prevalence of Elevated Alanine Transaminase and its Possible Causes in the General Korean Population. Journal of Clinical Gastroenterology 2014;48:534-9. [DOI: 10.1097/mcg.0b013e3182a474d3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
314 Ljumovic D, Diamantis I, Alegakis AK, Kouroumalis EA. Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases. Clin Chim Acta. 2004;349:203-211. [PMID: 15469875 DOI: 10.1016/j.cccn.2004.06.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
315 Nishide T, Ikeda K, Kawamura Y, Hosaka T, Kobayashi M, Suzuki Y, Kumada H. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period: Improvement of NASH with weight loss. Liver International 2007;27:1422-7. [DOI: 10.1111/j.1478-3231.2007.01574.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
316 Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J Clin Gastroenterol. 2004;38:801-804. [PMID: 15365409 DOI: 10.1097/01.mcg.0000139072.38580.a0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 4.1] [Reference Citation Analysis]
317 Sumida Y, Murotani K, Saito M, Tamasawa A, Osonoi Y, Yoneda M, Osonoi T. Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial). Hepatol Res. 2019;49:64-71. [PMID: 30051943 DOI: 10.1111/hepr.13236] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
318 Degrace P, Demizieux L, Du Z, Gresti J, Caverot L, Djaouti L, Jourdan T, Moindrot B, Guilland J, Hocquette J, Clouet P. Regulation of Lipid Flux between Liver and Adipose Tissue during Transient Hepatic Steatosis in Carnitine-depleted Rats. Journal of Biological Chemistry 2007;282:20816-26. [DOI: 10.1074/jbc.m611391200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
319 Yoshida C, Kojima H, Iijima T, Katsura Y, Shimizu S, Suzukawa K, Mukai HY, Hasegawa Y, Abei M, Nagasawa T. Association of non-alcoholic steatohepatitis (NASH) with chronic neutrophilic leukemia: Association of NASH with CNL. European Journal of Haematology 2004;72:225-8. [DOI: 10.1046/j.0902-4441.2003.00203.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
320 Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 2002;105:2923-8. [PMID: 12070124 DOI: 10.1161/01.cir.0000017823.53114.4c] [Cited by in Crossref: 156] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
321 Wan ZH, Wu FM. Curcumin and silymarin for nonalcoholic steatohepatitis in rats: Comparison of effects and mechanisms. Shijie Huaren Xiaohua Zazhi 2015; 23(8): 1285-1289 [DOI: 10.11569/wcjd.v23.i8.1285] [Reference Citation Analysis]
322 Kawanaka M, Nishino K, Nakamura J, Suehiro M, Goto D, Urata N, Oka T, Kawamoto H, Nakamura H, Yodoi J. Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study. Hepat Med. 2013;5:11-16. [PMID: 24695939 DOI: 10.2147/hmer.s41258] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
323 Paris T, George ES, Roberts SK, Tierney AC. The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 2017;29:867-78. [DOI: 10.1097/meg.0000000000000890] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
324 Pirgon Ö, Bilgin H, Çekmez F, Kurku H, Dündar BN. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2013;5:33-39. [PMID: 23367495 DOI: 10.4274/jcrpe.825] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
325 Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology. 2007;132:282-293. [PMID: 17241878 DOI: 10.1053/j.gastro.2006.10.014] [Cited by in Crossref: 161] [Cited by in F6Publishing: 164] [Article Influence: 10.1] [Reference Citation Analysis]
326 Zhu MJ, Sun LJ, Liu YQ, Feng YL, Tong HT, Hu YH, Zhao Z. Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis. World J Gastroenterol 2008; 14(29): 4677-4683 [PMID: 18698683 DOI: 10.3748/wjg.14.4677] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
327 Obara N, Fukushima K, Ueno Y, Wakui Y, Kimura O, Tamai K, Kakazu E, Inoue J, Kondo Y, Ogawa N, Sato K, Tsuduki T, Ishida K, Shimosegawa T. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J Hepatol. 2010;53:326-334. [PMID: 20462650 DOI: 10.1016/j.jhep.2010.02.029] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
328 Seko Y, Sumida Y, Sasaki K, Itoh Y, Iijima H, Hashimoto T, Ishii S, Inagaki N. Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials. J Gastroenterol 2018;53:140-51. [DOI: 10.1007/s00535-017-1364-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
329 Liu Z, Que S, Ning H, Wang L, Peng T. Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studies. PLoS One 2013;8:e80596. [PMID: 24324614 DOI: 10.1371/journal.pone.0080596] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]